Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Neutralizing antibody responses 10 months after mild and moderately-severe SARS-CoV-2 infection

View ORCID ProfilePuya Dehgani-Mobaraki, View ORCID ProfileAsiya Kamber Zaidi, View ORCID ProfileAnnamaria Porreca, Alessandro Floridi, Emanuela Floridi
doi: https://doi.org/10.1101/2021.02.22.21252225
Puya Dehgani-Mobaraki
1Founder and President, Association “Naso Sano”, Umbria Regional Registry of volunteer activities, Corciano, Italy Consultant, Gubbio-Gualdo Tadino Hospital, Usl Umbria 1, Italy Front Line COVID-19 Critical Care Alliance Associate (FLCCC)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Puya Dehgani-Mobaraki
Asiya Kamber Zaidi
2Member, Association “Naso Sano”, Umbria Regional Registry of volunteer activities, Corciano, Italy Senior Registrar, Mahatma Gandhi Memorial Medical College and M.Y.H hospital, Indore, MP, India Front Line COVID-19 Critical Care Alliance member (FLCCC); Fellow, World Academy of Medical Sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Asiya Kamber Zaidi
  • For correspondence: asiyazaidia@gmail.com
Annamaria Porreca
3Ph.D student, University “G.d’ Annunzio”, Chieti-Pescara,Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annamaria Porreca
Alessandro Floridi
4Laboratory of Nuclear Lipid BioPathology, Centro Ricerche Analisi Biochimico Specialistiche, Perugia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emanuela Floridi
4Laboratory of Nuclear Lipid BioPathology, Centro Ricerche Analisi Biochimico Specialistiche, Perugia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

can be made available on request

Back to top
PreviousNext
Posted February 23, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Neutralizing antibody responses 10 months after mild and moderately-severe SARS-CoV-2 infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Neutralizing antibody responses 10 months after mild and moderately-severe SARS-CoV-2 infection
Puya Dehgani-Mobaraki, Asiya Kamber Zaidi, Annamaria Porreca, Alessandro Floridi, Emanuela Floridi
medRxiv 2021.02.22.21252225; doi: https://doi.org/10.1101/2021.02.22.21252225
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Neutralizing antibody responses 10 months after mild and moderately-severe SARS-CoV-2 infection
Puya Dehgani-Mobaraki, Asiya Kamber Zaidi, Annamaria Porreca, Alessandro Floridi, Emanuela Floridi
medRxiv 2021.02.22.21252225; doi: https://doi.org/10.1101/2021.02.22.21252225

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (420)
  • Anesthesia (97)
  • Cardiovascular Medicine (898)
  • Dentistry and Oral Medicine (169)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (405)
  • Epidemiology (8774)
  • Forensic Medicine (4)
  • Gastroenterology (404)
  • Genetic and Genomic Medicine (1858)
  • Geriatric Medicine (178)
  • Health Economics (387)
  • Health Informatics (1288)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (206)
  • HIV/AIDS (392)
  • Infectious Diseases (except HIV/AIDS) (10550)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1750)
  • Nursing (102)
  • Nutrition (265)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (963)
  • Ophthalmology (282)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (41)
  • Pathology (263)
  • Pediatrics (556)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (218)
  • Psychiatry and Clinical Psychology (1842)
  • Public and Global Health (3979)
  • Radiology and Imaging (653)
  • Rehabilitation Medicine and Physical Therapy (343)
  • Respiratory Medicine (534)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (196)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)